Global Facial Aesthetics Sales 麻豆原创 Report, Competitive Analysis and Regional Opportunities 2025-2031

Publication ID:

PB504253497

Publication Date:

April 3, 2025

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,250.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Facial Aesthetics market size was US$ 66920 million in 2024 and is forecast to a readjusted size of US$ 249730 million by 2031 with a CAGR of 21.0% during the forecast period 2025-2031.
Facial Aesthetics involves appearance lifting and medical treatment that help people to have facial appearance which they are more satisfied. There are various methods to reach this demand, including facial surgery, injection, minimal invasive face-lifting, etc.
North America is the largest producer of Facial Aesthetics, with a market share nearly 60%銆侫llergan, Merz Aesthetics, Galderma, Valeant Pharmaceuticals and Mentor Worldwide are the top 5 manufacturers of industry.
The global Facial Aesthetics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
麻豆原创 Segmentation
By Company:
Allergan
Merz Aesthetics
Galderma
Bausch Health
Mentor Worldwide
Anika Therapeutics
Adoderm
Teoxane
Laboratories Vivacy
Prollenium Medical
Speciality European
Laboratories Org茅v
MD Skin Solutions
Laboratoires Filorga
Revitacare
Suneva Medical
SciVision Biotech
By Type: (Dominant Segment vs High-Margin Innovation)
Facial Surgical Procedures
Non-Surgical Procedures
By Application: (Core Demand Driver vs Emerging Opportunity)
Beauty Salon
Hospital
By Region
Macro-Regional Analysis: 麻豆原创 Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local 麻豆原创 Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Allergan in Europe)
- Emerging Product Trends: Facial Surgical Procedures adoption vs. Non-Surgical Procedures premiumization
- Demand-Side Dynamics: Beauty Salon growth in China vs. Hospital potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus 麻豆原创s:
North America
Europe
China
South Korea
South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Facial Aesthetics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis 鈥� Uncovering blue ocean markets (e.g., Non-Surgical Procedures in China).
Chapter 5: Application-based segmentation analysis 鈥� High-growth downstream opportunities (e.g., Hospital in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles 鈥� Financials, product portfolios, and strategic developments.
Chapter 8: 麻豆原创 dynamics 鈥� Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Facial Aesthetics value chain, addressing:
- 麻豆原创 entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 by Type
1.2.1 Global 麻豆原创 Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Facial Surgical Procedures
1.2.3 Non-Surgical Procedures
1.3 麻豆原创 by Application
1.3.1 Global 麻豆原创 Share by Application: 2020 VS 2024 VS 2031
1.3.2 Beauty Salon
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Facial Aesthetics 麻豆原创 Perspective (2020-2031)
2.2 Global 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.3 Global Facial Aesthetics Revenue 麻豆原创 Share by Region (2020-2025)
2.4 Global Facial Aesthetics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging 麻豆原创 Analysis
2.5.1 North America Facial Aesthetics 麻豆原创 Size and Prospective (2020-2031)
2.5.2 Europe Facial Aesthetics 麻豆原创 Size and Prospective (2020-2031)
2.5.3 China Facial Aesthetics 麻豆原创 Size and Prospective (2020-2031)
2.5.4 South Korea Facial Aesthetics 麻豆原创 Size and Prospective (2020-2031)
2.5.5 South America Facial Aesthetics 麻豆原创 Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Facial Aesthetics Historic 麻豆原创 Size by Type (2020-2025)
3.2 Global Facial Aesthetics Forecasted 麻豆原创 Size by Type (2026-2031)
3.3 Different Types Facial Aesthetics Representative Players
4 Breakdown Data by Application
4.1 Global Facial Aesthetics Historic 麻豆原创 Size by Application (2020-2025)
4.2 Global Facial Aesthetics Forecasted 麻豆原创 Size by Application (2026-2031)
4.3 New Sources of Growth in Facial Aesthetics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Facial Aesthetics Players by Revenue (2020-2025)
5.1.2 Global Facial Aesthetics Revenue 麻豆原创 Share by Players (2020-2025)
5.2 Global 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Facial Aesthetics Revenue
5.4 Global Facial Aesthetics 麻豆原创 Concentration Analysis
5.4.1 Global Facial Aesthetics 麻豆原创 Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Facial Aesthetics Revenue in 2024
5.5 Global Key Players of Facial Aesthetics Head office and Area Served
5.6 Global Key Players of Facial Aesthetics, Product and Application
5.7 Global Key Players of Facial Aesthetics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America 麻豆原创: Players, Segments and Downstream
6.1.1 North America Facial Aesthetics Revenue by Company (2020-2025)
6.1.2 North America 麻豆原创 Size by Type
6.1.2.1 North America Facial Aesthetics 麻豆原创 Size by Type (2020-2025)
6.1.2.2 North America Facial Aesthetics 麻豆原创 Share by Type (2020-2025)
6.1.3 North America 麻豆原创 Size by Application
6.1.3.1 North America Facial Aesthetics 麻豆原创 Size by Application (2020-2025)
6.1.3.2 North America Facial Aesthetics 麻豆原创 Share by Application (2020-2025)
6.1.4 North America 麻豆原创 Trend and Opportunities
6.2 Europe 麻豆原创: Players, Segments and Downstream
6.2.1 Europe Facial Aesthetics Revenue by Company (2020-2025)
6.2.2 Europe 麻豆原创 Size by Type
6.2.2.1 Europe Facial Aesthetics 麻豆原创 Size by Type (2020-2025)
6.2.2.2 Europe Facial Aesthetics 麻豆原创 Share by Type (2020-2025)
6.2.3 Europe 麻豆原创 Size by Application
6.2.3.1 Europe Facial Aesthetics 麻豆原创 Size by Application (2020-2025)
6.2.3.2 Europe Facial Aesthetics 麻豆原创 Share by Application (2020-2025)
6.2.4 Europe 麻豆原创 Trend and Opportunities
6.3 China 麻豆原创: Players, Segments and Downstream
6.3.1 China Facial Aesthetics Revenue by Company (2020-2025)
6.3.2 China 麻豆原创 Size by Type
6.3.2.1 China Facial Aesthetics 麻豆原创 Size by Type (2020-2025)
6.3.2.2 China Facial Aesthetics 麻豆原创 Share by Type (2020-2025)
6.3.3 China 麻豆原创 Size by Application
6.3.3.1 China Facial Aesthetics 麻豆原创 Size by Application (2020-2025)
6.3.3.2 China Facial Aesthetics 麻豆原创 Share by Application (2020-2025)
6.3.4 China 麻豆原创 Trend and Opportunities
6.4 South Korea 麻豆原创: Players, Segments and Downstream
6.4.1 South Korea Facial Aesthetics Revenue by Company (2020-2025)
6.4.2 South Korea 麻豆原创 Size by Type
6.4.2.1 South Korea Facial Aesthetics 麻豆原创 Size by Type (2020-2025)
6.4.2.2 South Korea Facial Aesthetics 麻豆原创 Share by Type (2020-2025)
6.4.3 South Korea 麻豆原创 Size by Application
6.4.3.1 South Korea Facial Aesthetics 麻豆原创 Size by Application (2020-2025)
6.4.3.2 South Korea Facial Aesthetics 麻豆原创 Share by Application (2020-2025)
6.4.4 South Korea 麻豆原创 Trend and Opportunities
6.5 South America 麻豆原创: Players, Segments and Downstream
6.5.1 South America Facial Aesthetics Revenue by Company (2020-2025)
6.5.2 South America 麻豆原创 Size by Type
6.5.2.1 South America Facial Aesthetics 麻豆原创 Size by Type (2020-2025)
6.5.2.2 South America Facial Aesthetics 麻豆原创 Share by Type (2020-2025)
6.5.3 South America 麻豆原创 Size by Application
6.5.3.1 South America Facial Aesthetics 麻豆原创 Size by Application (2020-2025)
6.5.3.2 South America Facial Aesthetics 麻豆原创 Share by Application (2020-2025)
6.5.4 South America 麻豆原创 Trend and Opportunities
7 Key Players Profiles
7.1 Allergan
7.1.1 Allergan Company Details
7.1.2 Allergan Business Overview
7.1.3 Allergan Facial Aesthetics Introduction
7.1.4 Allergan Revenue in Facial Aesthetics Business (2020-2025)
7.1.5 Allergan Recent Development
7.2 Merz Aesthetics
7.2.1 Merz Aesthetics Company Details
7.2.2 Merz Aesthetics Business Overview
7.2.3 Merz Aesthetics Facial Aesthetics Introduction
7.2.4 Merz Aesthetics Revenue in Facial Aesthetics Business (2020-2025)
7.2.5 Merz Aesthetics Recent Development
7.3 Galderma
7.3.1 Galderma Company Details
7.3.2 Galderma Business Overview
7.3.3 Galderma Facial Aesthetics Introduction
7.3.4 Galderma Revenue in Facial Aesthetics Business (2020-2025)
7.3.5 Galderma Recent Development
7.4 Bausch Health
7.4.1 Bausch Health Company Details
7.4.2 Bausch Health Business Overview
7.4.3 Bausch Health Facial Aesthetics Introduction
7.4.4 Bausch Health Revenue in Facial Aesthetics Business (2020-2025)
7.4.5 Bausch Health Recent Development
7.5 Mentor Worldwide
7.5.1 Mentor Worldwide Company Details
7.5.2 Mentor Worldwide Business Overview
7.5.3 Mentor Worldwide Facial Aesthetics Introduction
7.5.4 Mentor Worldwide Revenue in Facial Aesthetics Business (2020-2025)
7.5.5 Mentor Worldwide Recent Development
7.6 Anika Therapeutics
7.6.1 Anika Therapeutics Company Details
7.6.2 Anika Therapeutics Business Overview
7.6.3 Anika Therapeutics Facial Aesthetics Introduction
7.6.4 Anika Therapeutics Revenue in Facial Aesthetics Business (2020-2025)
7.6.5 Anika Therapeutics Recent Development
7.7 Adoderm
7.7.1 Adoderm Company Details
7.7.2 Adoderm Business Overview
7.7.3 Adoderm Facial Aesthetics Introduction
7.7.4 Adoderm Revenue in Facial Aesthetics Business (2020-2025)
7.7.5 Adoderm Recent Development
7.8 Teoxane
7.8.1 Teoxane Company Details
7.8.2 Teoxane Business Overview
7.8.3 Teoxane Facial Aesthetics Introduction
7.8.4 Teoxane Revenue in Facial Aesthetics Business (2020-2025)
7.8.5 Teoxane Recent Development
7.9 Laboratories Vivacy
7.9.1 Laboratories Vivacy Company Details
7.9.2 Laboratories Vivacy Business Overview
7.9.3 Laboratories Vivacy Facial Aesthetics Introduction
7.9.4 Laboratories Vivacy Revenue in Facial Aesthetics Business (2020-2025)
7.9.5 Laboratories Vivacy Recent Development
7.10 Prollenium Medical
7.10.1 Prollenium Medical Company Details
7.10.2 Prollenium Medical Business Overview
7.10.3 Prollenium Medical Facial Aesthetics Introduction
7.10.4 Prollenium Medical Revenue in Facial Aesthetics Business (2020-2025)
7.10.5 Prollenium Medical Recent Development
7.11 Speciality European
7.11.1 Speciality European Company Details
7.11.2 Speciality European Business Overview
7.11.3 Speciality European Facial Aesthetics Introduction
7.11.4 Speciality European Revenue in Facial Aesthetics Business (2020-2025)
7.11.5 Speciality European Recent Development
7.12 Laboratories Org茅v
7.12.1 Laboratories Org茅v Company Details
7.12.2 Laboratories Org茅v Business Overview
7.12.3 Laboratories Org茅v Facial Aesthetics Introduction
7.12.4 Laboratories Org茅v Revenue in Facial Aesthetics Business (2020-2025)
7.12.5 Laboratories Org茅v Recent Development
7.13 MD Skin Solutions
7.13.1 MD Skin Solutions Company Details
7.13.2 MD Skin Solutions Business Overview
7.13.3 MD Skin Solutions Facial Aesthetics Introduction
7.13.4 MD Skin Solutions Revenue in Facial Aesthetics Business (2020-2025)
7.13.5 MD Skin Solutions Recent Development
7.14 Laboratoires Filorga
7.14.1 Laboratoires Filorga Company Details
7.14.2 Laboratoires Filorga Business Overview
7.14.3 Laboratoires Filorga Facial Aesthetics Introduction
7.14.4 Laboratoires Filorga Revenue in Facial Aesthetics Business (2020-2025)
7.14.5 Laboratoires Filorga Recent Development
7.15 Revitacare
7.15.1 Revitacare Company Details
7.15.2 Revitacare Business Overview
7.15.3 Revitacare Facial Aesthetics Introduction
7.15.4 Revitacare Revenue in Facial Aesthetics Business (2020-2025)
7.15.5 Revitacare Recent Development
7.16 Suneva Medical
7.16.1 Suneva Medical Company Details
7.16.2 Suneva Medical Business Overview
7.16.3 Suneva Medical Facial Aesthetics Introduction
7.16.4 Suneva Medical Revenue in Facial Aesthetics Business (2020-2025)
7.16.5 Suneva Medical Recent Development
7.17 SciVision Biotech
7.17.1 SciVision Biotech Company Details
7.17.2 SciVision Biotech Business Overview
7.17.3 SciVision Biotech Facial Aesthetics Introduction
7.17.4 SciVision Biotech Revenue in Facial Aesthetics Business (2020-2025)
7.17.5 SciVision Biotech Recent Development
8 Facial Aesthetics 麻豆原创 Dynamics
8.1 Facial Aesthetics Industry Trends
8.2 Facial Aesthetics 麻豆原创 Drivers
8.3 Facial Aesthetics 麻豆原创 Challenges
8.4 Facial Aesthetics 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 麻豆原创 Size Estimation
10.1.1.3 麻豆原创 Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Allergan
Merz Aesthetics
Galderma
Bausch Health
Mentor Worldwide
Anika Therapeutics
Adoderm
Teoxane
Laboratories Vivacy
Prollenium Medical
Speciality European
Laboratories Org茅v
MD Skin Solutions
Laboratoires Filorga
Revitacare
Suneva Medical
SciVision Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.